Arca
Skip to content
Tools
Tools

Pervasive child development disorder

Drug research and approvals for pervasive child development disorder: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 344 studies of pervasive child development disorder are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 344
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 344 recruiting on ClinicalTrials.gov ↗

How its trials ended

546 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 73 whose ending is known, 36% met their primary endpoint, 10% missed it and 55% stopped early.

  • Completed, result not reported24545%
  • Ongoing16330%
  • Status unknown6512%
  • Met its primary endpoint265%
  • Stopped: other or unclear224%
  • Stopped: lack of efficacy92%
  • Missed its primary endpoint71%
  • Stopped: enrollment or feasibility41%
  • Stopped: funding31%
  • Stopped: sponsor or business decision2<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.